US Patent Issued to INTRON BIOTECHNOLOGY on Dec. 23 for "Antibacterial protein CDL200 having lytic activity against Clostridioides difficile" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,494, issued on Dec. 23, was assigned to INTRON BIOTECHNOLOGY INC. (Gyeonggi-Do, South Korea).

"Antibacterial protein CDL200 having lytic activity against Clostridioides difficile" was invented by Seong Jun Yoon (Seoul, South Korea), Jee Soo Son (Seoul, South Korea), In Hwang Kim (Gyeonggi-do, South Korea), Cheol Ahn (Gyeonggi-do, South Korea), Soo Youn Jun (Seoul, South Korea) and Sang Hyeon Kang (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an antibacterial protein CDL200 with an antibacterial activity specific against Clostridioides difficile. More specifically, the present invention relates to...